Investigating how eosinophils contribute to blood clotting and artery disease in people with LNK deficiency
The role of eosinophil in thrombosis and atherosclerosis in LNK deficiency
This study is looking at how a type of white blood cell called eosinophils might play a role in blood clots and artery disease, especially in people with a specific genetic condition, to help find new ways to prevent heart problems.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10999452 on NIH RePORTER |
What this research studies
This research explores the role of eosinophils, a type of white blood cell, in the development of blood clots and artery disease, particularly in individuals with a specific genetic variant known as LNK deficiency. The study utilizes mouse models to understand how this deficiency affects blood cell behavior and contributes to cardiovascular issues. By examining the interactions between eosinophils, neutrophils, and platelets, the research aims to uncover new therapeutic targets for preventing atherothrombotic cardiovascular disease. Patients may benefit from insights that could lead to novel treatments tailored to their genetic profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with LNK deficiency, particularly those from African American, European, or Latin American backgrounds.
Not a fit: Patients without LNK deficiency or those not affected by atherothrombotic cardiovascular disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that specifically target eosinophils to reduce the risk of blood clots and artery disease.
How similar studies have performed: Other research has shown promising results in understanding the role of eosinophils in cardiovascular diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Wang, Nan — Columbia University Health Sciences
- Study coordinator: Wang, Nan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.